.png)
Needle Free Drug Delivery Devices Market by Technology and Application - Global Industry Analysis and Forecast to 2022
Published On : June 2017 Pages : 75 Category: Medical Devices Report Code : HC0681
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Industry Trend Analysis
Needle Free Drug Delivery Devices Market is expected to experience a moderate growth in coming years between 2017 and 2022. The market is expected to reach $3.43 billion by 2022 at a significantly growing CAGR of 12.36%. The increasing cases of chronic diseases such as Hepatitis B, Hepatitis C and AIDS, increasing need for self-administration of drugs especially in cases of diabetes and pain-free drug delivery will boost the market growth in the upcoming years. The incidence of chronic diseases especially AIDS has become a common phenomenon across the globe. AIDS mainly occur due to extensive and frequent application of injections to an individual. For instance, as per WHO, the transmission of diseases through the use of injections has increased more than 19.7% across the globe. This fact indicates the chance of increasing demand of the market across the globe. In addition, the technological advancements related to this field will also enhance the growth of the market over the forecast period. The drug delivery devices are programmed in such a manner, that it ensures slow and controlled flow of drug into the body as per patient’s requirement thereby the risk of side-effects also gets reduced. However, the high cost of devices and lack of awareness among the general population will restrain the market growth in the upcoming years. Thus, considering the drivers and restrains, the market is expected to show moderate growth over the forecast period.
Product Outlook and Trend Analysis
Need free drug delivery devices are used to administer protein such as β-interferon. They are used to deliver insulin in patients suffering from diabetes. Self-administration is possible with these devices. They are more convenient, less expensive and safer to use. Needle free drug delivery devices are available in various designs such as skin patches, nose drops, and nasal sprays. The patches are embedded with tiny blades. The drug is transferred into the skin with help of these tiny blades. Nasal sprays deliver the drug through the mucous membrane. Inhalers are another kind of needle free delivery devices in which the drug is atomized. This ensures required amount of drug delivery to the patient. Components of the needle free devices are nozzle, drug reservoir, and pressure source. These devices can be given by intramuscular, intradermal or subcutaneous route.
Regional Outlook and Trend Analysis
North America held a significant share of the needle free drug delivery devices market in 2022 due to the increase in occurrence of chronic diseases especially AIDS in various states. In addition, technological innovation of the devices by the key players of the market will also enhance the market growth in this region. The Asia-Pacific market has not experienced any substantial growth due to lack of large scale adoption of needle free drug delivery devices but can experience favorable growth in coming years owing to changing lifestyles related to needle free drug delivery devices and increasing cases of chronic diseases in the region.
Competitive Outlook and Trend Analysis
The key players operating in the needle free drug delivery devices market emphasize on product development in order to introduce improved drug delivery devices and capture a larger share of the market. Some of the major players in this market Akra DermoJet, Antares Pharma, PharmaJet Inc., Valeritas Inc., 3M, Injex Pharma AG and Penjet Corporation.
Market Opportunities
The key opportunity for the players operating in needle free drug delivery devices market lies in the development of various types of cost effective drug delivery devices for better assistance of the patients. Apart from that, innovative marketing strategies will further broaden the opportunities of the key players to grow significantly over the forecast period. In addition, changing lifestyles for drug delivery devices, will further increase demand of this market, creating a lucrative opportunities for growth, for the key players of this market.
Needle Free Drug Delivery Devices Market Segmentation:
By Technology
- Novel Needle Free Technologies
- Jet Injectors
- Transdermal Patch Technology
- Inhaler Technology
By Application
- Pediatric Injections
- Vaccine Delivery
- Insulin Delivery for Diabetes
- Pain Management
- Others
By Region:
- North America
- U.S
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia Pacific
- Rest of the World
- Brazil
- South Africa
- Saudi Arabia
- United Arab Emirates
- Others
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2022 to 2027?
- What will be the industry market growth from 2022 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
- Needle Free Drug Delivery Devices Market, By Technology, Estimates and Forecast, 2014-2022 ($Billion)
- Novel Needle Free Technologies
- Jet Injectors
- Transdermal Patch Technology
- Inhaler Technology
- Needle Free Drug Delivery Devices Market, By Application, Estimates and Forecast, 2014-2022 ($Billion)
- Pediatric Injections
- Vaccine Delivery
- Insulin Delivery for Diabetes
- Pain Management
- Others
- Needle Free Drug Delivery Devices Market, By Region, Estimates and Forecast, 2014-2022 ($Billion)
- North America
- North America Needle Free Drug Delivery Devices Market, By Country
- North America Needle Free Drug Delivery Devices Market, By Technology
- North America Needle Free Drug Delivery Devices Market, By Application
- U.S. Needle Free Drug Delivery Devices Market, By Technology
- U.S. Needle Free Drug Delivery Devices Market, By Application
- Canada Needle Free Drug Delivery Devices Market, By Technology
- Canada Needle Free Drug Delivery Devices Market, By Application
- Mexico Needle Free Drug Delivery Devices Market, By Technology
- Mexico Needle Free Drug Delivery Devices Market, By Application
- North America
-
- Europe
- Europe Needle Free Drug Delivery Devices Market, By Country
- Europe Needle Free Drug Delivery Devices Market, By Technology
- Europe Needle Free Drug Delivery Devices Market, By Application
- Germany Needle Free Drug Delivery Devices Market, By Technology
- Germany Needle Free Drug Delivery Devices Market, By Application
- France Needle Free Drug Delivery Devices Market, By Technology
- France Needle Free Drug Delivery Devices Market, By Application
- UK Needle Free Drug Delivery Devices Market, By Technology
- UK Needle Free Drug Delivery Devices Market, By Application
- Italy Needle Free Drug Delivery Devices Market, By Technology
- Italy Needle Free Drug Delivery Devices Market, By Application
- Spain Needle Free Drug Delivery Devices Market, By Technology
- Spain Needle Free Drug Delivery Devices Market, By Application
- Rest of Europe Needle Free Drug Delivery Devices Market, By Technology
- Rest of Europe Needle Free Drug Delivery Devices Market, By Application
-
- Asia-Pacific
- Asia-Pacific Needle Free Drug Delivery Devices Market, By Country
- Asia-Pacific Needle Free Drug Delivery Devices Market, By Technology
- Asia-Pacific Needle Free Drug Delivery Devices Market, By Application
- Japan Needle Free Drug Delivery Devices Market, By Technology
- Japan Needle Free Drug Delivery Devices Market, By Application
- Australia Needle Free Drug Delivery Devices Market, By Technology
- Australia Needle Free Drug Delivery Devices Market, By Application
- India Needle Free Drug Delivery Devices Market, By Technology
- India Needle Free Drug Delivery Devices Market, By Application
- South Korea Needle Free Drug Delivery Devices Market, By Technology
- South Korea Needle Free Drug Delivery Devices Market, By Application
- Rest of Asia-Pacific Needle Free Drug Delivery Devices Market, By Technology
- Rest of Asia-Pacific Needle Free Drug Delivery Devices Market, By Application
- Asia-Pacific
-
- Rest of the World
- Rest of the World Needle Free Drug Delivery Devices Market, By Country
- Rest of the World Needle Free Drug Delivery Devices Market, By Technology
- Rest of the World Needle Free Drug Delivery Devices Market, By Application
- Brazil Needle Free Drug Delivery Devices Market, By Technology
- Brazil Needle Free Drug Delivery Devices Market, By Application
- South Africa Needle Free Drug Delivery Devices Market, By Technology
- South Africa Needle Free Drug Delivery Devices Market, By Application
- Saudi Arabia Needle Free Drug Delivery Devices Market, By Technology
- Saudi Arabia Needle Free Drug Delivery Devices Market, By Application
- Turkey Needle Free Drug Delivery Devices Market, By Technology
- Turkey Needle Free Drug Delivery Devices Market, By Application
- United Arab Emirates Needle Free Drug Delivery Devices Market, By Technology
- United Arab Emirates Needle Free Drug Delivery Devices Market, By Application
- Others Needle Free Drug Delivery Devices Market, By Technology
- Others Needle Free Drug Delivery Devices Market, By Application
- Rest of the World
Table of Contents
1.Introduction
1.1.Report Description
1.2.Research Methodology
2.Executive Summary
2.1.Key Highlights
3.Market Overview
3.1.Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2.Market Share Analysis
3.3.Market Dynamics
3.3.1. Drivers
3.3.1.1.IncreasingCases of Chronic Diseases
3.3.1.2.Technological Innovation and Low Risk of Getting Side-Effects
3.3.1.3.Changing Lifestyles and Increasing Adoption
3.3.2. Restraints
3.3.2.1.High Pricing of the Technology
3.3.2.2.Low Awareness among General Population
3.3.3. Opportunities
3.3.3.1.Emerging Markets to Offer Lucrative Growth Opportunities
3.4.Industry Trends
4.Needle Free Drug Delivery Devices Market, By Technology
4.1.Introduction
4.2.Needle Free Drug Delivery Devices Market Assessment and Forecast, By Technology, 2017-2022
4.3.Novel Needle Free Technologies
4.3.1. Market Assessment and Forecast, By Region, 2017-2022 ($Billion)
4.4.Jet Injectors
4.4.1. Market Assessment and Forecast, By Region, 2017-2022 ($Billion)
4.5.Transdermal Patch Technology
4.5.1. Market Assessment and Forecast, By Region, 2017-2022 ($Billion)
4.6.Inhaler Technology
4.6.1. Market Assessment and Forecast, By Region, 2017-2022 ($Billion)
5.Needle Free Drug Delivery Devices Market, By Application
5.1.Introduction
5.2.The Needle Free Drug Delivery Devices Market Assessment and Forecast, By Application, 2017-2022
5.3.Pediatric Injections
5.3.1. Market Assessment and Forecast, By Region, 2017-2022 ($Billion)
5.4.Vaccine Delivery
5.4.1. Market Assessment and Forecast, By Region, 2017-2022 ($Billion)
5.5.Insulin Delivery for Diabetes
5.5.1. Market Assessment and Forecast, By Region, 2017-2022 ($Billion)
5.6.Pain Management
5.6.1. Market Assessment and Forecast, By Region, 2017-2022 ($Billion)
5.7.Others
5.7.1. Market Assessment and Forecast, By Region, 2017-2022 ($Billion)
6.Needle Free Drug Delivery Devices Market, By Region
6.1.Introduction
6.2.Needle Free Drug Delivery Devices Market Assessment and Forecast, By Technology, 2017-2022 ($Billion)
6.3.Needle Free Drug Delivery Devices Market Assessment and Forecast, By Application , 2017-2022 ($Billion)
6.4.North America
6.4.1. Market Assessment and Forecast, By Country, 2017-2022 ($Billion)
6.4.2. Market Assessment and Forecast, By Technology, 2017-2022 ($Billion)
6.4.3. Market Assessment and Forecast, By Application, 2017-2022 ($Billion)
6.4.4. U.S.
6.4.4.1.Market Assessment and Forecast, By Technology, 2017-2022 ($Billion)
6.4.4.2.Market Assessment and Forecast, By Application, 2017-2022 ($Billion)
6.4.5. Canada
6.4.5.1.Market Assessment and Forecast, By Technology, 2017-2022 ($Billion)
6.4.5.2.Market Assessment and Forecast, By Application, 2017-2022 ($Billion)
6.4.6. Mexico
6.4.6.1.Market Assessment and Forecast, By Technology, 2017-2022 ($Billion)
6.4.6.2.Market Assessment and Forecast, By Application, 2017-2022 ($Billion)
6.5.Europe
6.5.1. Market Assessment and Forecast, By Country, 2017-2022 ($Billion)
6.5.2. Market Assessment and Forecast, By Technology, 2017-2022 ($Billion)
6.5.3. Market Assessment and Forecast, By Application, 2017-2022 ($Billion)
6.5.4. Germany
6.5.4.1.Market Assessment and Forecast, By Technology, 2017-2022 ($Billion)
6.5.4.2.Market Assessment and Forecast, By Application, 2017-2022 ($Billion)
6.5.5. France
6.5.5.1.Market Assessment and Forecast, By Technology, 2017-2022 ($Billion)
6.5.5.2.Market Assessment and Forecast, By Application, 2017-2022 ($Billion)
6.5.6. UK
6.5.6.1.Market Assessment and Forecast, By Technology, 2017-2022 ($Billion)
6.5.6.2.Market Assessment and Forecast, By Application, 2017-2022 ($Billion)
6.5.7. Italy
6.5.7.1.Market Assessment and Forecast, By Technology, 2017-2022 ($Billion)
6.5.7.2.Market Assessment and Forecast, By Application, 2017-2022 ($Billion)
6.5.8. Spain
6.5.8.1.Market Assessment and Forecast, By Technology, 2017-2022 ($Billion)
6.5.8.2.Market Assessment and Forecast, By Application, 2017-2022 ($Billion)
6.5.9. Russia
6.5.9.1.Market Assessment and Forecast, By Technology, 2017-2022 ($Billion)
6.5.9.2.Market Assessment and Forecast, By Application, 2017-2022 ($Billion)
6.5.10.Rest of Europe
6.5.10.1.Market Assessment and Forecast, By Technology, 2017-2022 ($Billion)
6.5.10.2.Market Assessment and Forecast, By Application, 2017-2022 ($Billion)
6.6.Asia-Pacific
6.6.1. Market Assessment and Forecast, By Country, 2017-2022 ($Billion)
6.6.2. Market Assessment and Forecast, By Technology, 2017-2022 ($Billion)
6.6.3. Market Assessment and Forecast, By Application, 2017-2022 ($Billion)
6.6.4. Japan
6.6.4.1.Market Assessment and Forecast, By Technology, 2017-2022 ($Billion)
6.6.4.2.Market Assessment and Forecast, By Application, 2017-2022 ($Billion)
6.6.5. China
6.6.5.1.Market Assessment and Forecast, By Technology, 2017-2022 ($Billion)
6.6.5.2.Market Assessment and Forecast, By Application, 2017-2022 ($Billion)
6.6.6. Australia
6.6.6.1.Market Assessment and Forecast, By Technology, 2017-2022 ($Billion)
6.6.6.2.Market Assessment and Forecast, By Application, 2017-2022 ($Billion)
6.6.7. India
6.6.7.1.Market Assessment and Forecast, By Technology, 2017-2022 ($Billion)
6.6.7.2.Market Assessment and Forecast, By Application, 2017-2022 ($Billion)
6.6.8. South Korea
6.6.8.1.Market Assessment and Forecast, By Technology, 2017-2022 ($Billion)
6.6.8.2.Market Assessment and Forecast, By Application, 2017-2022 ($Billion)
6.6.9. Taiwan
6.6.9.1.Market Assessment and Forecast, By Technology, 2017-2022 ($Billion)
6.6.9.2.Market Assessment and Forecast, By Application, 2017-2022 ($Billion)
6.6.10.Rest of Asia-Pacific
6.6.10.1.Market Assessment and Forecast, By Technology, 2017-2022 ($Billion)
6.6.10.2.Market Assessment and Forecast, By Application, 2017-2022 ($Billion)
6.7.Rest of the World
6.7.1. Market Assessment and Forecast, By Country, 2017-2022 ($Billion)
6.7.2. Market Assessment and Forecast, By Technology, 2017-2022 ($Billion)
6.7.3. Market Assessment and Forecast, By Application, 2017-2022 ($Billion)
6.7.4. Brazil
6.7.4.1.Market Assessment and Forecast, By Technology, 2017-2022 ($Billion)
6.7.4.2.Market Assessment and Forecast, By Application, 2017-2022 ($Billion)
6.7.5. Turkey
6.7.5.1.Market Assessment and Forecast, By Technology, 2017-2022 ($Billion)
6.7.5.2.Market Assessment and Forecast, By Application, 2017-2022 ($Billion)
6.7.6. Saudi Arabia
6.7.6.1.Market Assessment and Forecast, By Technology, 2017-2022 ($Billion)
6.7.6.2.Market Assessment and Forecast, By Application, 2017-2022 ($Billion)
6.7.7. South Africa
6.7.7.1.Market Assessment and Forecast, By Technology, 2017-2022 ($Billion)
6.7.7.2.Market Assessment and Forecast, By Application, 2017-2022 ($Billion)
6.7.8. United Arab Emirates
6.7.8.1.Market Assessment and Forecast, By Technology, 2017-2022 ($Billion)
6.7.8.2.Market Assessment and Forecast, By Application, 2017-2022 ($Billion)
6.7.9. Others
6.7.9.1.Market Assessment and Forecast, By Technology, 2017-2022 ($Billion)
6.7.9.2.Market Assessment and Forecast, By Application, 2017-2022 ($Billion)
7.Company Profiles
7.1.Arka DermoJet
7.1.1. Business Overview
7.1.2. ProductPortfolio
7.1.3. Strategic Developments
7.2.Antares Pharma
7.2.1. Business Overview
7.2.2. Product Portfolio
7.2.3. Key Financials
7.2.4. Strategic Developments
7.3.PharmaJet Inc
7.3.1. Business Overview
7.3.2. ProductPortfolio
7.3.3. Strategic Developments
7.4.Valeritas,Inc.
7.4.1. Business Overview
7.4.2. ProductPortfolio
7.4.3. Key Financials
7.4.4. Strategic Developments
7.5.3M
7.5.1. Business Overview
7.5.2. ProductPortfolio
7.5.3. Strategic Developments
7.6.Injex Pharma AG
7.6.1. Business Overview
7.6.2. ProductPortfolio
7.6.3. Strategic Developments
7.7.Penjet Corporation
7.7.1. Business Overview
7.7.2. ProductPortfolio
7.7.3. Strategic Developments
List of Tables
Table 1.Global Needle Free Drug Delivery Devices Market, By Technology, 2017-2022 ($Billion)
Table 2.Novel Needle Free Technologies Market, By Region, 2017-2022 ($Billion)
Table 3.Jet Injectors Market, By Region, 2017-2022 ($Billion)
Table 4.Transdermal Patch Technology Market, By Region, 2017-2022 ($Billion)
Table 5.Inhaler Technology Market, By Region, 2017-2022 ($Billion)
Table 6.Needle Free Drug Delivery Devices Market, By Application, 2017-2022 ($Billion)
Table 7.Pediatric Injections Market, By Region, 2017-2022 ($Billion)
Table 8.Vaccind Delivery Market, By Region, 2017-2022 ($Billion)
Table 9.Insulin Delivery for Diabetes Market, By Region, 2017-2022 ($Billion)
Table 10.Pain Management Market, By Region, 2017-2022 ($Billion)
Table 11.Others Market, By Region, 2017-2022 ($Billion)
Table 12.North America Needle Free Drug Delivery Devices Market, By Country, 2017-2022 ($Billion)
Table 13.North America Needle Free Drug Delivery Devices Market, By Technology, 2017-2022 ($Billion)
Table 14.North America Needle Free Drug Delivery Devices Market, By Application, 2017-2022 ($Billion)
Table 15.U.S. Needle Free Drug Delivery Devices Market, By Technology, 2017-2022 ($Billion)
Table 16.U.S. Needle Free Drug Delivery Devices Market, By Application, 2017-2022 ($Billion)
Table 17.Canada Needle Free Drug Delivery Devices Market, By Technology, 2017-2022 ($Billion)
Table 18.Canada Needle Free Drug Delivery Devices Market, By Application, 2017-2022 ($Billion)
Table 19.Mexico Needle Free Drug Delivery Devices Market, By Technology, 2017-2022 ($Billion)
Table 20.Mexico Needle Free Drug Delivery Devices Market, By Application, 2017-2022 ($Billion)
Table 21.Europe Needle Free Drug Delivery Devices Market, By Country, 2017-2022 ($Billion)
Table 22.Europe Needle Free Drug Delivery Devices Market, By Technology, 2017-2022 ($Billion)
Table 23.Europe Needle Free Drug Delivery Devices Market, By Application, 2017-2022 ($Billion)
Table 24.Germany Needle Free Drug Delivery Devices Market, By Technology, 2017-2022 ($Billion)
Table 25.Germany Needle Free Drug Delivery Devices Market, By Application, 2017-2022 ($Billion)
Table 26.France Needle Free Drug Delivery Devices Market, By Technology, 2017-2022 ($Billion)
Table 27.France Needle Free Drug Delivery Devices Market, By Application, 2017-2022 ($Billion)
Table 28.UK Needle Free Drug Delivery Devices Market, By Technology, 2017-2022 ($Billion)
Table 29.UK Needle Free Drug Delivery Devices Market, By Application, 2017-2022 ($Billion)
Table 30.Italy Needle Free Drug Delivery Devices Market, By Technology, 2017-2022 ($Billion)
Table 31.Italy Needle Free Drug Delivery Devices Market, By Application, 2017-2022 ($Billion)
Table 32.Spain Needle Free Drug Delivery Devices Market, By Technology, 2017-2022 ($Billion)
Table 33.Spain Needle Free Drug Delivery Devices Market, By Application, 2017-2022 ($Billion)
Table 34.Russia Needle Free Drug Delivery Devices Market, By Technology, 2017-2022 ($Billion)
Table 35.Russia Needle Free Drug Delivery Devices Market, By Application, 2017-2022 ($Billion)
Table 36.Rest of Europe Needle Free Drug Delivery Devices Market, By Technology, 2017-2022 ($Billion)
Table 37.Rest of Europe Needle Free Drug Delivery Devices Market, By Application, 2017-2022 ($Billion)
Table 38.Asia-Pacific Needle Free Drug Delivery Devices Market, By Country, 2017-2022 ($Billion)
Table 39.Asia-Pacific Needle Free Drug Delivery Devices Market, By Technology, 2017-2022 ($Billion)
Table 40.Asia-Pacific Needle Free Drug Delivery Devices Market, By Application, 2017-2022 ($Billion)
Table 41.Japan Needle Free Drug Delivery Devices Market, By Technology, 2017-2022 ($Billion)
Table 42.Japan Needle Free Drug Delivery Devices Market, By Application, 2017-2022 ($Billion)
Table 43.China Needle Free Drug Delivery Devices Market, By Technology, 2017-2022 ($Billion)
Table 44.China Needle Free Drug Delivery Devices Market, By Application, 2017-2022 ($Billion)
Table 45.Australia Needle Free Drug Delivery Devices Market, By Technology, 2017-2022 ($Billion)
Table 46.Australia Needle Free Drug Delivery Devices Market, By Application, 2017-2022 ($Billion)
Table 47.India Needle Free Drug Delivery Devices Market, By Technology, 2017-2022 ($Billion)
Table 48.India Needle Free Drug Delivery Devices Market, By Application, 2017-2022 ($Billion)
Table 49.South Korea Needle Free Drug Delivery Devices Market, By Technology, 2017-2022 ($Billion)
Table 50.South Korea Needle Free Drug Delivery Devices Market, By Application, 2017-2022 ($Billion)
Table 51.Rest of Asia-Pacific Needle Free Drug Delivery Devices Market, By Technology, 2017-2022 ($Billion)
Table 52.Rest of Asia-Pacific Needle Free Drug Delivery Devices Market, By Application, 2017-2022 ($Billion)
Table 53.Rest of the World Needle Free Drug Delivery Devices Market, By Country, 2017-2022 ($Billion)
Table 54.Rest of the World Needle Free Drug Delivery Devices Market, By Technology, 2017-2022 ($Billion)
Table 55.Rest of the World Needle Free Drug Delivery Devices Market, By Application, 2017-2022 ($Billion)
Table 56.Brazil Needle Free Drug Delivery Devices Market, By Technology, 2017-2022 ($Billion)
Table 57.Brazil Needle Free Drug Delivery Devices Market, By Application, 2017-2022 ($Billion)
Table 58.Turkey Needle Free Drug Delivery Devices Market, By Technology, 2017-2022 ($Billion)
Table 59.Turkey Needle Free Drug Delivery Devices Market, By Application, 2017-2022 ($Billion)
Table 60.Saudi Arabia Needle Free Drug Delivery Devices Market, By Technology, 2017-2022 ($Billion)
Table 61.Saudi Arabia Needle Free Drug Delivery Devices Market, By Application, 2017-2022 ($Billion)
Table 62.South Africa Needle Free Drug Delivery Devices Market, By Technology, 2017-2022 ($Billion)
Table 63.South Africa Needle Free Drug Delivery Devices Market, By Application, 2017-2022 ($Billion)
Table 64.United Arab Emirates Needle Free Drug Delivery Devices Market, By Technology, 2017-2022 ($Billion)
Table 65.United Arab Emirates Needle Free Drug Delivery Devices Market, By Application, 2017-2022 ($Billion)
Table 66.Others Needle Free Drug Delivery Devices Market, By Technology, 2017-2022 ($Billion)
Table 67.Others Needle Free Drug Delivery Devices Market, By Application, 2017-2022 ($Billion)
Table 68.Arka DermoJet: Key Strategic Developments, 2017-2017
Table 69.Antares Pharma: Key Strategic Developments, 2017-2017
Table 70.PharmaJet Inc: Key Strategic Developments, 2017-2017
Table 71.Valeritas, Inc.: Key Strategic Developments, 2017-2017
Table 72.3M: Key Strategic Developments, 2017-2017
Table 73.Injex Pharma AG: Key Strategic Developments, 2017-2017
Table 74.Penjet Corporation: Key Strategic Developments, 2017-2017
List of Figures
Figure 1.Global Needle Free Drug Delivery Devices Market Share, By Technology, 2017 & 2025
Figure 2.Global Needle Free Drug Delivery Devices Market, By Application, 2017, ($Billion)
Figure 3.Global Needle Free Drug Delivery Devices Market, By Region, 2017, ($Billion)
Figure 4.Antares Pharma: Net Revenues, 2017-2017 ($Billion)
Figure 5.Antares Pharma: Net Revenue Share, By Segment, 2017
Figure 6.Antares Pharma: Net Revenue Share, By Geography, 2017
Figure 7.Valeritas, Inc.: Net Revenues, 2017-2017 ($Billion)
Figure 8.Valeritas, Inc.: Net Revenue Share, By Segment, 2017
Figure 9.Valeritas, Inc.: Net Revenue Share, By Geography, 2017
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|